
OneVentures
Description
OneVentures is a prominent Australian venture capital firm headquartered in Sydney, recognized for its strategic investments in high-growth technology and healthcare companies. Established as one of Australia's leading VCs, the firm manages over A$1 billion (approximately US$660 million) in funds under management, demonstrating significant capital deployment capacity. Their investment thesis centers on identifying companies with disruptive technologies, robust intellectual property, and substantial global market potential, aiming to back businesses poised for significant scale and impact.
The firm primarily targets companies in their Series A and Series B funding rounds, providing crucial capital during key growth phases. OneVentures is known for its flexible investment approach, offering both equity and venture credit solutions to its portfolio companies. Initial equity investments typically range from A$5 million to A$20 million (approximately US$3.3 million to US$13.2 million), allowing them to support a diverse range of innovative ventures from early growth to more mature stages. This dual investment strategy provides founders with tailored financing options, catering to different capital needs and growth trajectories.
OneVentures distinguishes itself through its deep sector expertise, particularly in areas like deep tech, life sciences, and digital health. They not only provide capital but also actively engage with portfolio companies, offering strategic guidance, operational support, and access to their extensive network to accelerate growth and facilitate global expansion. With a strong track record of successful exits and a commitment to fostering innovation within the Australian ecosystem and beyond, OneVentures plays a vital role in shaping the future of technology and healthcare.
Investor Profile
OneVentures has backed more than 26 startups, with 2 new investments in the last 12 months alone. The firm has led 10 rounds, about 38% of its total and boasts 8 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in Australia, United States, Singapore.
- Strong thematic focus on Software, SaaS, Biotechnology.
- Led 2 rounds in the past year.
- Typical check size: $3.3M – $13.2M.
Stage Focus
- Series A (31%)
- Series B (23%)
- Series C (15%)
- Series Unknown (12%)
- Corporate Round (4%)
- Series D (4%)
- Series F (4%)
- Series E (4%)
- Seed (4%)
Country Focus
- Australia (58%)
- United States (38%)
- Singapore (4%)
Industry Focus
- Software
- Saas
- Biotechnology
- Health Care
- Telecommunications
- Medical Device
- Analytics
- Internet
- Machine Learning
- Mobile
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.